Trial Profile
Phase II Randomized Study With Capecitabine Versus 5-Fluorouracil / Leucovorin in Bolus Associated with Radiotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: INCAGI004.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Jul 2022
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 04 Jul 2022 Results assessing impact of clinical response and surgical resection on QOL , published in the Supportive Care in Cancer.
- 12 Feb 2018 New trial record